Sociedad Americana de Hirudoterapia

Microbiota Dynamics: A Key Factor in Hirudotherapy-Related Infections?

Microbiology article published in Microorganisms (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSeguridad y control de infeccionesGenómica y proteómicaKarasartova D, Arslan-Akveran G, Sensoz S, Mumcuoglu KY, Taylan-Ozkan A · Microorganisms, 2025

Abstract

The gastrointestinal microbiota of medicinal leeches is particularly interesting due to their blood-feeding habits, increasing medical use, and risk of pathogen transmission. Three groups of Hirudo verbana were used to study the leech microbiota: farmed leeches fasting for a long time, farmed leeches recently fed with bovine blood, and wild specimens fed with amphibian blood. The microbiota of the leeches' mouth, pharynx, crop, and intestine was analyzed. Metasequencing analyses were performed using amplification of the 16S rRNA V3-V4 region on a NovaSeq Illumina platform. The relative abundance of bacterial microbiota included environmental bacteria from the families Rhizobiaceae, Comamonadaceae, Sphingobacteriaceae, Phreatobacteraceae, Myxococcaceae, Chitinophagaceae, Rhodospirillaceae, and Bdellovibrionaceae, as well as symbiotic/probiotic bacteria such as Mucinivorans, Aeromonas, Vagococcus, Lactobacillales, and Morganella. Significant differences were found in the different regions of the digestive system among the three groups of leeches, and environmental bacteria were present in all groups to varying degrees. A negative correlation was found between the dominant environmental and the symbiotic/probiotic bacteria. In contrast, a positive correlation was found between environmental and symbiotic/probiotic bacteria, indicating their association with host factors. Microbiota diversity, abundance, and bacterial correlations may be influenced by factors such as the leech's fasting state, blood meal source, and environmental conditions. The identified opportunistic pathogens, such as Rickettsia, Anaplasma, and Treponema, identified for the first time in H. verbana, should be taken into consideration when using this leech in hirudotherapy. Our results show that extensive screening for opportunistic and pathogenic agents should be performed on leeches intended for medical use. Long-fasting leeches and leeches cultured in specialized farms are recommended for hirudotherapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

16S rRNA V3-V4 metagenomics across three Hirudo verbana groups (long-fasting farmed, recently-fed farmed, wild) identifies opportunistic pathogens including Pseudomonas, Sphingobacterium, and Stenotrophomonas, recommending long-fasting farm-raised leeches for clinical use.

Por qué esto importa para la hirudoterapia

This study analyzed mouth, pharynx, crop, and intestine microbiota of three Hirudo verbana groups (long-fasting farmed, recently bovine-blood-fed farmed, and wild amphibian-blood-fed) using 16S rRNA V3-V4 metasequencing, finding symbiotic/probiotic bacteria (Mucinivorans, Aeromonas, Vagococcus, Lactobacillales, Morganella), environmental bacteria, and opportunistic pathogens including Rickettsia, Anaplasma, and Treponema newly identified in H. verbana. Microbiota varied by digestive region, fasting state, blood source, and environment. For ASH, this is directly relevant to hirudotherapy safety, supporting extensive pathogen screening of medicinal leeches and preferential use of long-fasting farmed leeches. The caveat is that this is a leech microbiota study, not a human clinical trial, and it characterizes risk rather than documenting clinical infections.

Citación

Microbiota Dynamics: A Key Factor in Hirudotherapy-Related Infections?

Karasartova D, Arslan-Akveran G, Sensoz S, Mumcuoglu KY, Taylan-Ozkan A · Microorganisms, 2025

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.